Alpha-1 adrenergic antagonists, 5-alpha reductase inhibitors, phosphodiesterase type 5 inhibitors, and phytotherapic compounds in men with lower urinary tract symptoms suggestive of benign prostatic obstruction: A systematic review and meta-analysis of ur-Reference-Cited by-同舟云学术

Alpha-1 adrenergic antagonists, 5-alpha reductase inhibitors, phosphodiesterase type 5 inhibitors, and phytotherapic compounds in men with lower urinary tract symptoms suggestive of benign prostatic obstruction: A systematic review and meta-analysis of ur

Published:2018-03-31 Issue:6 Volume:37 Page:1865-1874
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourology and Urodynamics

Author:

Fusco Ferdinando¹²^ORCID,Creta Massimiliano¹,De Nunzio Cosimo²³^ORCID,Gacci Mauro²⁴,Li Marzi Vincenzo²⁴,Finazzi Agrò Enrico²⁵^ORCID

Affiliation:

1. Department of Neurosciences; Human Reproduction and Odontostomatology; University of Naples; Naples Italy

2. Italian Society of Urodynamics Publication Group; Naples Italy

3. Department of Urology; “Sapienza” University of Rome; Sant'Andrea Hospital; Rome Italy

4. Department of Urology; University of Florence; Careggi Hospital; Florence Italy

5. Department of Experimental and Surgical Medicine; Urology Clinic; University “Tor Vergata”; Roma Italy

Publisher

Wiley

Subject

Urology,Clinical Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/nau.23554/fullpdf

Reference43 articles.

1. Effect of bladder outlet obstruction on the morphology, physiology, and pharmacology of the bladder;Levin;Prostate Suppl,1990

2. The evolution of alpha-blockers for the treatment of benign prostatic hyperplasia;Lepor;Rev Urol,2006

3. Benign prostatic obstruction relief in patients with lower urinary tract symptoms suggestive of benign prostatic enlargement undergoing endoscopic surgical procedures or therapy with alpha-Blockers: a review of urodynamic studies;Fusco;Adv Ther,2017

4. Benign prostatic hyperplasia: an overview of existing treatment;Dhingra;Indian J Pharmacol,2011

5. European Association of Urology. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptomsincluding benign prostatic obstruction;Oelke;Eur Urol,2013

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Konservative und medikamentöse Therapie des benignen Prostatasyndroms;Die Urologie;2023-10

2. Adverse events related to alpha-blockers: analysis of real-life data from Eudra-Vigilance;Minerva Urology and Nephrology;2023-08

3. Functional and oncological outcomes after radical prostatectomy in patients with history of surgery for lower urinary tract symptoms related to benign prostatic enlargement: A systematic review with meta-analysis;Prostate Cancer and Prostatic Diseases;2023-05-27

4. Lipid Profile and 5α-Reductase Inhibition Activity of Proprietary Ultrahigh-Pressure Supercritical Carbon Dioxide and Hexane Saw Palmetto Extracts;Uro;2023-01-17

5. Efficacy and safety of adrenergic alpha-1 receptor antagonists in older adults: a systematic review and meta-analysis supporting the development of recommendations to reduce potentially inappropriate prescribing;BMC Geriatrics;2022-09-28